Cargando…
MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
Gastroenterological cancers are the most common cancers categorized by systems and are estimated to comprise 18.4% of all cancers in the United States in 2017. Gastroenterological cancers are estimated to contribute 26.2% of cancer-related death in 2017. Gastroenterological cancers are characterized...
Autores principales: | Yang, Yixin, Alderman, Christopher, Sehlaoui, Ayoub, Xiao, Yuan, Wang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038585/ https://www.ncbi.nlm.nih.gov/pubmed/30046565 http://dx.doi.org/10.1155/2018/9740357 |
Ejemplares similares
-
Gastroenterological Cancer and Immunotherapy
por: Wang, Xiaoping, et al.
Publicado: (2018) -
The Roles of MiRNAs (MicroRNAs) in Melanoma Immunotherapy
por: Dong, Linyinxue, et al.
Publicado: (2022) -
MicroRNA as a Biomarker in Gastroenterological Cancers
por: Morishita, Asahiro, et al.
Publicado: (2022) -
MicroRNAs in T Cell-Immunotherapy
por: Dosil, Sara G., et al.
Publicado: (2022) -
MicroRNAs: immune modulators in cancer immunotherapy
por: Xing, Yun, et al.
Publicado: (2021)